Genetic Landscape of Amyotrophic Lateral Sclerosis in Czech Patients

被引:0
|
作者
Baumgartner, Daniel [1 ,2 ]
Musova, Zuzana [2 ,3 ]
Zidkova, Jana [4 ,5 ]
Hedvicakova, Petra [2 ,3 ]
Vlckova, Eva [5 ,6 ]
Joppekova, Lubica [5 ,6 ]
Kramarova, Tereza [4 ,5 ]
Fajkusova, Lenka [4 ,5 ]
Stranecky, Viktor [7 ,8 ]
Geryk, Jan [2 ,3 ]
Votypka, Pavel [2 ,3 ]
Mazanec, Radim [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med 2, Neuromuscular Ctr, Dept Neurol, 5Uvalu 84, Prague 15006, Czech Republic
[2] Univ Hosp Motol, 5Uvalu 84, Prague 15006, Czech Republic
[3] Charles Univ Prague, Fac Med 2, Dept Biol & Med Genet, Prague, Czech Republic
[4] Univ Hosp Brno, Masaryk Univ Brno, Ctr Mol Biol & Genet, Internal Haematol & Oncol Clin, Brno, Czech Republic
[5] Masaryk Univ Brno, Fac Med, Brno, Czech Republic
[6] Univ Hosp Brno, Masaryk Univ, Neuromuscular Ctr, Dept Neurol, Brno, Czech Republic
[7] Charles Univ Prague, Fac Med 1, Dept Pediat & Inherited Metab Disorders, Res Unit Rare Dis, Prague, Czech Republic
[8] Gen Univ Hosp, Prague, Czech Republic
关键词
Amyotrophic lateral sclerosis; neurogenetics; mutation screening; C9orf72 repeat expansion; next-generation sequencing; gene variants; GGGGCC HEXANUCLEOTIDE REPEAT; SPASTIN GENE; ALS; VARIANTS; ONSET; MUTATIONS; EXOME;
D O I
10.3233/JND-230236
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Genetic factors are involved in the pathogenesis of familial and sporadic amyotrophic lateral sclerosis (ALS) and constitute a link to its association with frontotemporal dementia (FTD). Gene-targeted therapies for some forms of ALS (C9orf72, SOD1) have recently gained momentum. Genetic architecture in Czech ALS patients has not been comprehensively assessed so far. Objective: We aimed to deliver pilot data on the genetic landscape of ALS in our country. Methods: A cohort of patients with ALS (n n = 88), recruited from two Czech Neuromuscular Centers, was assessed for hexanucleotide repeat expansion (HRE) in C9orf72 and also for genetic variations in other 36 ALS-linked genes via next- generation sequencing (NGS). Nine patients (10.1%) had a familial ALS. Further, we analyzed two subgroups of sporadic patients - with concomitant FTD (n n =7) and with young-onset of the disease (n n = 22). Results: We detected the pathogenic HRE in C9orf72 in 12 patients (13.5%) and three other pathogenic variants in FUS, TARDBP and TBK1, each in one patient. Additional 7 novel and 9 rare known variants with uncertain causal significance have been detected in 15 patients. Three sporadic patients with FTD (42.9%) were harbouring a pathogenic variant (all HRE in C9orf72). Surprisingly, none of the young-onset sporadic patients harboured a pathogenic variant and we detected no pathogenic SOD1 variant in our cohort. Conclusion: Our findings resemble those from other European populations, with the highest prevalence of HRE in the C9orf72 gene. Further, our findings suggest a possibility of a missing genetic variability among young-onset patients.
引用
收藏
页码:1035 / 1048
页数:14
相关论文
共 50 条
  • [1] Genetic defects causing Amyotrophic lateral sclerosis in Czech Republic
    Kara, Nazli S.
    Khazaal, Magui
    Navratilova, Nela
    Markova, Lucia
    Slachtova, Lenka
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 512 - 512
  • [2] Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients
    Lamp, Merit
    Origone, Paola
    Geroldi, Alessandro
    Verdiani, Simonetta
    Gotta, Fabio
    Caponnetto, Claudia
    Devigili, Grazia
    Verriello, Lorenzo
    Scialo, Carlo
    Cabona, Corrado
    Canosa, Antonio
    Vanni, Irene
    Bellone, Emilia
    Eleopra, Roberto
    Mandich, Paola
    NEUROBIOLOGY OF AGING, 2018, 66 : 179.e5 - 179.e16
  • [3] Genetic studies of Russian patients with amyotrophic lateral sclerosis
    Lysogorskaia, Elena V.
    Abramycheva, Nataliya Yu
    Zakharova, Mariya N.
    Stepanova, Mariya S.
    Moroz, Anna A.
    Rossokhin, Alexey V.
    Illarioshkin, Sergey N.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2016, 17 (1-2) : 135 - 141
  • [4] Amyotrophic Lateral Sclerosis (ALS) Genetic Testing: Current Landscape and Potential Needs
    Salmon, Kristiana
    Glass, Jonathan
    Genge, Angela
    Chockalingam, Priya
    Runz, Heiko
    Fradette, Stephanie
    Cochrane, Thos
    Kupelian, Varant
    NEUROLOGY, 2021, 96 (15)
  • [5] Characterizing the epigenetic landscape of amyotrophic lateral sclerosis
    Bennett, S. A.
    Tanaz, R.
    Cobos, S. N.
    Yousuf, H.
    Fallah, M.
    Elegendy, A.
    Mirzakandova, M.
    Angelakakis, G.
    Salib, B.
    Torrente, M. P.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26) : 342 - 342
  • [6] Genetic testing in amyotrophic lateral sclerosis
    Nakken, Ola
    Holmoy, Trygve
    Sorum, Lillian
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2018, 138 (13) : 1251 - 1255
  • [7] Genetic testing in amyotrophic lateral sclerosis
    Ludolph, Albert C.
    NATURE REVIEWS NEUROLOGY, 2017, 13 (05) : 262 - 263
  • [8] Genetic testing in amyotrophic lateral sclerosis
    Albert C. Ludolph
    Nature Reviews Neurology, 2017, 13 : 262 - 263
  • [9] Genetic approximation in amyotrophic lateral sclerosis
    Cervantes-Aragon, Ivan
    Alberto Ramirez-Garcia, Sergio
    Margarita Baltazar-Rodriguez, Luz
    Garcia-Cruz, Diana
    Castaneda-Cisneros, Gema
    GACETA MEDICA DE MEXICO, 2019, 155 (05): : 513 - 521
  • [10] Genetic epidemiology of amyotrophic lateral sclerosis
    Majoor-Krakauer, D
    Willems, PJ
    Hofman, A
    CLINICAL GENETICS, 2003, 63 (02) : 83 - 101